Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mavena Health is a Swiss pharmaceutical company dedicated to the development of innovative medical skin care solutions for chronic inflammatory skin conditions. The company is best known for its patented Vitamin B12 technology, which utilizes cyanocobalamin as a nitric oxide scavenger to reduce inflammation and itching in patients with psoriasis and atopic dermatitis. Their product portfolio includes specialized creams, ointments, and gels that are clinically proven to restore the skin's natural barrier function without the use of corticosteroids. Mavena's treatments are primarily marketed as Class IIa medical devices across Europe and other international territories. By focusing on high-quality, non-steroidal alternatives, the company addresses a significant unmet need for long-term management of chronic dermatological diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mavena Health.